📗 Cite This Artifact
TUBA1A Protein
TUBA1A Protein — Tubulin Alpha 1A
<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">TUBA1A Protein</th></tr>
<tr><td><strong>Protein Name</strong></td><td>Tubulin Alpha 1A</td></tr>
<tr><td><strong>Gene</strong></td><td>[TUBA1A](/entities/tuba1a)</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[P68366](https://www.uniprot.org/uniprot/P68366)</td></tr>
<tr><td><strong>PDB ID</strong></td><td>1JFF, 4I55</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>~50.1 kDa (451 amino acids)</td></tr>
<tr><td><strong>Subcellular Localization</strong></td><td>Cytoskeleton, microtubules</td></tr>
<tr><td><strong>Protein Family</strong></td><td>Tubulin superfamily, alpha-tubulin</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>Lissencephaly type 3, cortical dysplasia</td></tr>
</table>
</div>
Overview
...
TUBA1A Protein — Tubulin Alpha 1A
<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">TUBA1A Protein</th></tr>
<tr><td><strong>Protein Name</strong></td><td>Tubulin Alpha 1A</td></tr>
<tr><td><strong>Gene</strong></td><td>[TUBA1A](/entities/tuba1a)</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[P68366](https://www.uniprot.org/uniprot/P68366)</td></tr>
<tr><td><strong>PDB ID</strong></td><td>1JFF, 4I55</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>~50.1 kDa (451 amino acids)</td></tr>
<tr><td><strong>Subcellular Localization</strong></td><td>Cytoskeleton, microtubules</td></tr>
<tr><td><strong>Protein Family</strong></td><td>Tubulin superfamily, alpha-tubulin</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>Lissencephaly type 3, cortical dysplasia</td></tr>
</table>
</div>
Overview
TUBA1A (Tubulin Alpha 1A) encodes the most abundantly expressed alpha-tubulin isotype in the developing and adult brain[@luduea2013]. Alpha- and beta-tubulin heterodimers polymerise to form microtubules — the major cytoskeletal scaffold of [neurons](/entities/neurons). Microtubules are essential for neuronal migration, axon guidance, intracellular transport, synaptic function, and cell division. Dominant TUBA1A mutations cause a spectrum of brain malformations collectively termed tubulinopathies, ranging from severe lissencephaly to subtle cortical dysplasia with intellectual disability and epilepsy[@bahibuisson2014]. Beyond developmental disorders, TUBA1A and the broader tubulin–microtubule system are increasingly recognised as relevant to neurodegenerative diseases where [tau](/proteins/tau)-mediated microtubule destabilisation, axonal transport failure, and cytoskeletal collapse are central pathogenic mechanisms[@brandt2020].
Structure
TUBA1A is a 451-amino-acid protein with the canonical tubulin fold[@luduea2013]:
- N-terminal domain (aa 1–205): Contains the GTP-binding site (non-exchangeable in alpha-tubulin; GTP is hydrolysed only after heterodimer incorporation into the microtubule lattice)
- Intermediate domain (aa 206–381): Mediates lateral contacts between protofilaments and interactions with microtubule-associated proteins (MAPs) including [tau](/proteins/tau) and MAP2
- C-terminal tail (aa 431–451): A highly acidic, glutamate-rich region exposed on the microtubule surface that undergoes extensive post-translational modifications (polyglutamylation, detyrosination, acetylation) — the "tubulin code"[@janke2020]
- Heterodimer interface: TUBA1A forms obligate heterodimers with beta-tubulin isotypes (primarily [TUBB3](/genes/tubb3) in neurons), assembling head-to-tail into 13-protofilament microtubule cylinders with defined polarity (minus-end at centrosome, plus-end at growth cone or synapse)
The crystal structure at 3.5 Å resolution reveals that most disease-causing mutations cluster at the heterodimer interface, the longitudinal contacts between dimers, or the binding surfaces for MAPs and motor proteins[@bahibuisson2014].
Normal Function
Microtubule Assembly and Dynamics
TUBA1A heterodimers undergo dynamic instability — stochastic switching between growth and shrinkage phases at the plus-end[@luduea2013]:
- Growth phase: GTP-loaded dimers add to the plus-end, forming a stabilising GTP cap
- Catastrophe: GTP hydrolysis within the lattice leads to GDP-tubulin, which favours curved protofilaments and rapid depolymerisation
- Rescue: Stochastic re-capping restores growth
- In mature neurons, microtubules are more stable than in dividing cells due to extensive post-translational modifications and MAP binding, but dynamic plus-ends persist at synapses and growth cones
Neuronal Migration
During cortical development, TUBA1A is the predominant alpha-tubulin in migrating neurons[@bahibuisson2014]:
- Radially migrating cortical neurons extend a leading process containing a microtubule cage (the "dilation") that pulls the nucleus forward (nucleokinesis)
- TUBA1A mutations disrupt the perinuclear microtubule cage, impairing nuclear translocation and causing ectopic neuron positioning (cortical malformations)
- The centrosome–nucleus coupling via dynein on TUBA1A-containing microtubules is essential for this process
Axonal Transport
Microtubules built from TUBA1A serve as the rails for long-range intracellular transport[@brandt2020]:
- Kinesin motors move cargo (mitochondria, synaptic vesicles, signalling endosomes) toward the plus-end (anterograde, cell body → synapse)
- Dynein motors move cargo toward the minus-end (retrograde, synapse → cell body)
- The tubulin code on the TUBA1A C-terminal tail directs motor selectivity: polyglutamylated microtubules preferentially recruit kinesin-1, while detyrosinated microtubules favour kinesin-2[@janke2020]
In mature neurons with axons exceeding 1 metre (motor neurons), microtubule-based transport is the sole mechanism for supplying distant synapses with proteins, mitochondria, and RNA.
Synaptic Function
At synapses, dynamic TUBA1A-containing microtubules transiently invade [dendritic spines](/mechanisms/dendritic-spines), delivering cargo and influencing spine morphology and synaptic plasticity[@jaworski2009]:
- Microtubule invasions of spines correlate with [LTP](/mechanisms/long-term-potentiation) and are activity-dependent
- Disruption of microtubule dynamics impairs AMPA receptor trafficking and long-term memory formation
Role in Neurodegeneration
Tubulinopathies (Developmental)
Dominant TUBA1A mutations cause a spectrum of malformations with neurodegeneration-like features[@bahibuisson2014][@keays2007]:
| Phenotype | Features | Common Mutations |
|-----------|----------|-----------------|
| Lissencephaly type 3 | Smooth brain, absent gyri, severe ID, epilepsy | R264C, R402H |
| Pachygyria | Thick gyri, moderate ID | Various missense |
| Polymicrogyria | Excessive small gyri, variable ID | P263L |
| Cortical dysplasia with cerebellar hypoplasia | Motor delay, ataxia, ID | L286F, R422H |
These mutations disrupt heterodimer folding (via chaperonin cofactor interactions), microtubule dynamics, or MAP/motor protein binding[@keays2007].
Tau-Mediated Neurodegeneration
TUBA1A is directly relevant to [tauopathies](/mechanisms/tauopathy) because tau is a microtubule-associated protein that binds the tubulin lattice[@brandt2020]:
- Normal tau function: [Tau](/proteins/tau) binds the TUBA1A–TUBB heterodimer interface and stabilises microtubules, promoting polymerisation and reducing catastrophe frequency
- Tau hyperphosphorylation (in [Alzheimer's disease](/diseases/alzheimers-disease), [PSP](/diseases/psp), [CBD](/diseases/cbd)): Phosphorylated tau detaches from microtubules → TUBA1A-containing microtubules become unstable → axonal transport collapses → synapses degenerate
- Tau aggregation: Detached tau forms paired helical filaments and neurofibrillary tangles, further depleting the functional tau pool and accelerating microtubule loss
- In AD [hippocampus](/brain-regions/hippocampus), total tubulin levels decrease by 30–40 % compared to age-matched controls, with TUBA1A among the most reduced isotypes[@zhang2015]
Axonal Transport Deficits
Microtubule destabilisation in neurodegeneration causes a cascade of transport failures[@brandt2020][@zhang2012]:
- Mitochondria cannot reach distant synapses → local energy crisis → synaptic failure
- Autophagosomes accumulate in axonal swellings (dystrophic neurites), a hallmark of AD
- BDNF-containing vesicles fail to reach synapses → loss of trophic support
- Microtubule-stabilising drugs ([epothilone D](/therapeutics/microtubule-stabilizers)) rescue axonal transport in tauopathy mouse models[@zhang2012]
Parkinson's Disease
[Alpha-synuclein](/proteins/alpha-synuclein) oligomers bind tubulin directly and impair microtubule polymerisation in vitro[@cartelli2016]. In LRRK2-G2019S PD models, hyperactive LRRK2 kinase phosphorylates tubulin-associated proteins, disrupting microtubule stability in dopaminergic neuron axons.
Post-Translational Modification Changes
The tubulin code is altered in neurodegenerative disease[@janke2020]:
- Reduced acetylation (at Lys40 of alpha-tubulin) correlates with microtubule instability in AD and HD
- Increased detyrosination marks stabilised but transport-impaired microtubules in aged neurons
- HDAC6 inhibitors that increase tubulin acetylation rescue axonal transport in multiple disease models
Therapeutic Implications
Microtubule-Stabilising Agents
- Epothilone D: Brain-penetrant microtubule stabiliser that reduces tau pathology and rescues axonal transport in PS19 tauopathy mice; clinical development was halted due to narrow therapeutic window[@zhang2012]
- Davunetide (NAP/AL-108): An 8-amino-acid peptide derived from activity-dependent neuroprotective protein (ADNP) that stabilises microtubules; Phase II/III trials in PSP were negative, but the concept of microtubule stabilisation remains promising[@boxer2014]
- Taxol derivatives: Paclitaxel rescues axonal transport in vitro but has poor [BBB](/entities/blood-brain-barrier) penetration
Tubulin Code Modifiers
- HDAC6 inhibitors (tubastatin A, ricolinostat): Increase alpha-tubulin acetylation, improve axonal transport, and are neuroprotective in AD, HD, and CMT2 models
- TTL/VASH modulators: Enzymes controlling the tyrosination–detyrosination cycle are emerging therapeutic targets
Gene Therapy for Tubulinopathies
For severe TUBA1A lissencephaly, antisense or gene replacement strategies are being explored in preclinical models, though the dominant-negative nature of most mutations complicates simple supplementation approaches.
See Also
- [Tau Protein](/proteins/tau)
- [TUBB3 Protein](/proteins/tubb3-protein)
- [Microtubule Dynamics in Neurodegeneration](/mechanisms/microtubule-dysfunction)
- [Axonal Transport Deficits](/mechanisms/axonal-transport-deficits)
- [Tauopathy](/mechanisms/tauopathy)
- [HDAC6 Inhibitors](/therapeutics/hdac6-inhibitors)
External Links
- [UniProt: P68366](https://www.uniprot.org/uniprot/P68366)
- [OMIM: 602529 — TUBA1A](https://omim.org/entry/602529)
- [GeneCards: TUBA1A](https://www.genecards.org/cgi-bin/carddisp.pl?gene=TUBA1A)
References
▸Metadataorigin_type: v1_polymorphic_backfill
| slug | proteins-tuba1a-protein |
| kg_node_id | TUBA1APROTEIN |
| entity_type | protein |
| origin_type | v1_polymorphic_backfill |
| source_table | wiki_pages |
| wiki_page_id | wp-b46096819023 |
| __merged_from | {'merged_at': '2026-05-13', 'unprefixed_id': 'proteins-tuba1a-protein'} |
| _schema_version | 1 |
No provenance edges found
Use ?embed=1 to load the artifact without SciDEX chrome — suitable for iframing into wiki pages or external sites.
<iframe src="http://scidex.ai/artifact/wiki-proteins-tuba1a-protein?embed=1" width="100%" height="600" style="border:0;border-radius:8px"></iframe>
[TUBA1A Protein](http://scidex.ai/artifact/wiki-proteins-tuba1a-protein)
http://scidex.ai/artifact/wiki-proteins-tuba1a-protein